Thiazide	thiazide	O	O
diuretics	diuretics	O	O
,	,	O	O
hypokalemia	hypokalemia	O	O
and	and	O	O
cardiac	cardiac	O	B_disease
arrhythmias	arrhythmias	O	S_disease
.	.	O	O

Thiazide	thiazide	O	O
diuretics	diuretics	O	O
are	are	O	O
widely	widely	O	O
accepted	accepted	O	O
as	as	O	O
the	the	O	O
cornerstone	cornerstone	O	O
of	of	O	O
antihypertensive	antihypertensive	O	O
treatment	treatment	O	O
programs	programs	O	O
.	.	O	O

Hypokalemia	hypokalemia	O	O
is	is	O	O
a	a	O	O
commonly	commonly	O	O
encountered	encountered	O	O
metabolic	metabolic	O	O
consequence	consequence	O	O
of	of	O	O
chronic	chronic	O	O
thiazide	thiazide	O	O
therapy	therapy	O	O
.	.	O	O

We	we	O	O
treated	treated	O	O
38	38	O	O
patients	patients	O	O
(	(	O	O
22	22	O	O
low	low	O	O
renin	renin	O	O
,	,	O	O
16	16	O	O
normal	normal	O	O
renin	renin	O	O
)	)	O	O
with	with	O	O
moderate	moderate	O	O
diastolic	diastolic	O	B_disease
hypertension	hypertension	O	S_disease
with	with	O	O
hydrochlorothiazide	hydrochlorothiazide	O	O
(	(	O	O
HCTC	hctc	O	O
)	)	O	O
administered	administered	O	O
on	on	O	O
a	a	O	O
twice	twice	O	O
daily	daily	O	O
schedule	schedule	O	O
.	.	O	O

Initial	initial	O	O
dose	dose	O	O
was	was	O	O
50	50	O	O
mg	mg	O	O
and	and	O	O
the	the	O	O
dose	dose	O	O
was	was	O	O
increased	increased	O	O
at	at	O	O
monthly	monthly	O	O
intervals	intervals	O	O
to	to	O	O
100	100	O	O
mg	mg	O	O
,	,	O	O
150	150	O	O
mg	mg	O	O
and	and	O	O
200	200	O	O
mg	mg	O	O
daily	daily	O	O
until	until	O	O
blood	blood	O	O
pressure	pressure	O	O
normalized	normalized	O	O
.	.	O	O

The	the	O	O
serum	serum	O	O
K	k	S_chemical	O
during	during	O	O
the	the	O	O
control	control	O	O
period	period	O	O
was	was	O	O
4.5	4.5	O	O
+	+	O	O
/-	/-	O	O
0.2	0.2	O	O
mEq/l	meq/l	O	O
an	an	O	O
on	on	O	O
50	50	O	O
,	,	O	O
100	100	O	O
,	,	O	O
150	150	O	O
and	and	O	O
200	200	O	O
mg	mg	O	O
HCTZ	hctz	S_chemical	O
daily	daily	O	O
3.9	3.9	O	O
+	+	O	O
/-	/-	O	O
0.3	0.3	O	O
,	,	O	O
3.4	3.4	O	O
+	+	O	O
/-	/-	O	O
0.2	0.2	O	O
,	,	O	O
2.9	2.9	O	O
+	+	O	O
/-	/-	O	O
0.2	0.2	O	O
,	,	O	O
and	and	O	O
2.4	2.4	O	O
+	+	O	O
/-	/-	O	O
0.3	0.3	O	O
mEq/l	meq/l	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Corresponding	corresponding	O	O
figures	figures	O	O
for	for	O	O
whole	whole	O	O
body	body	O	O
K	k	S_chemical	O
were	were	O	O
4107	4107	O	O
+	+	O	O
/-	/-	O	O
208	208	O	O
,	,	O	O
3722	3722	O	O
+	+	O	O
/-	/-	O	O
319	319	O	O
,	,	O	O
3628	3628	O	O
+	+	O	O
/-	/-	O	O
257	257	O	O
,	,	O	O
3551	3551	O	O
+	+	O	O
/-	/-	O	O
336	336	O	O
,	,	O	O
and	and	O	O
3269	3269	O	O
+	+	O	O
/-	/-	O	O
380	380	O	O
mEq	meq	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

In	in	O	O
13	13	O	O
patients	patients	O	O
we	we	O	O
observed	observed	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
HCTZ	hctz	S_chemical	O
therapy	therapy	O	O
(	(	O	O
100	100	O	O
mg	mg	O	O
daily	daily	O	O
)	)	O	O
on	on	O	O
the	the	O	O
occurrence	occurrence	O	O
of	of	O	O
PVC	pvc	O	O
's	's	O	O
during	during	O	O
rest	rest	O	O
as	as	O	O
well	well	O	O
as	as	O	O
during	during	O	O
static	static	O	O
and	and	O	O
dynamic	dynamic	O	O
exercise	exercise	O	O
.	.	O	O

During	during	O	O
rest	rest	O	O
we	we	O	O
observed	observed	O	O
0.6	0.6	O	O
+	+	O	O
/-	/-	O	O
0.08	0.08	O	O
PVC	pvc	O	O
beats/min	beats/min	O	O
+	+	O	O
/-	/-	O	O
SEM	sem	O	O
and	and	O	O
during	during	O	O
static	static	O	O
and	and	O	O
dynamic	dynamic	O	O
exercise	exercise	O	O
0.6	0.6	O	O
+	+	O	O
/-	/-	O	O
0.06	0.06	O	O
and	and	O	O
0.8	0.8	O	O
+	+	O	O
/-	/-	O	O
0.15	0.15	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Corresponding	corresponding	O	O
figures	figures	O	O
during	during	O	O
HCTZ	hctz	S_chemical	O
therapy	therapy	O	O
100	100	O	O
mg	mg	O	O
daily	daily	O	O
were	were	O	O
1.4	1.4	O	O
+	+	O	O
/-	/-	O	O
0.1	0.1	O	O
,	,	O	O
3.6	3.6	O	O
+	+	O	O
/-	/-	O	O
0.7	0.7	O	O
and	and	O	O
5.7	5.7	O	O
4/-	4/-	O	O
0.8	0.8	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

The	the	O	O
occurrence	occurrence	O	O
of	of	O	O
PVC	pvc	O	O
's	's	O	O
correlated	correlated	O	O
significantly	significantly	O	O
with	with	O	O
the	the	O	O
fall	fall	O	O
in	in	O	O
serum	serum	O	O
K+	k+	O	O
observed	observed	O	O
r	r	O	O
=	=	O	O
0.72	0.72	O	O
,	,	O	O
p	p	O	O
less	less	O	O
than	than	O	O
0.001	0.001	O	O
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
we	we	O	O
found	found	O	O
that	that	O	O
thiazide	thiazide	O	O
diuretics	diuretics	O	O
cause	cause	O	O
hypokalemia	hypokalemia	O	O
and	and	O	O
depletion	depletion	O	O
of	of	O	O
body	body	O	O
potassium	potassium	S_chemical	O
.	.	O	O

The	the	O	O
more	more	O	O
profound	profound	O	O
hypokalemia	hypokalemia	O	O
,	,	O	O
the	the	O	O
greater	greater	O	O
the	the	O	O
propensity	propensity	O	O
for	for	O	O
the	the	O	O
occurrence	occurrence	O	O
of	of	O	O
PVC	pvc	O	O
's	's	O	O
.	.	O	O

